CRBU
Price
$1.53
Change
-$0.01 (-0.65%)
Updated
Jan 17 closing price
Capitalization
138.55M
65 days until earnings call
VRDN
Price
$18.14
Change
+$1.09 (+6.39%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
1.44B
39 days until earnings call
Ad is loading...

CRBU vs VRDN

Header iconCRBU vs VRDN Comparison
Open Charts CRBU vs VRDNBanner chart's image
Caribou Biosciences
Price$1.53
Change-$0.01 (-0.65%)
Volume$1.03M
Capitalization138.55M
Viridian Therapeutics
Price$18.14
Change+$1.09 (+6.39%)
Volume$40.59K
Capitalization1.44B
CRBU vs VRDN Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. VRDN commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and VRDN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (CRBU: $1.53 vs. VRDN: $18.13)
Brand notoriety: CRBU and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 67% vs. VRDN: 78%
Market capitalization -- CRBU: $138.55M vs. VRDN: $1.44B
CRBU [@Biotechnology] is valued at $138.55M. VRDN’s [@Biotechnology] market capitalization is $1.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 1 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 3 bearish.
  • VRDN’s TA Score: 1 bullish, 5 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than VRDN.

Price Growth

CRBU (@Biotechnology) experienced а -6.71% price change this week, while VRDN (@Biotechnology) price change was -0.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

CRBU is expected to report earnings on May 13, 2025.

VRDN is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.44B) has a higher market cap than CRBU($139M). CRBU YTD gains are higher at: -3.774 vs. VRDN (-5.425). CRBU has higher annual earnings (EBITDA): -161.7M vs. VRDN (-253.41M). VRDN has more cash in the bank: 753M vs. CRBU (228M). VRDN has less debt than CRBU: VRDN (21.1M) vs CRBU (26.6M). CRBU has higher revenues than VRDN: CRBU (11.5M) vs VRDN (302K).
CRBUVRDNCRBU / VRDN
Capitalization139M1.44B10%
EBITDA-161.7M-253.41M64%
Gain YTD-3.774-5.42570%
P/E RatioN/AN/A-
Revenue11.5M302K3,808%
Total Cash228M753M30%
Total Debt26.6M21.1M126%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUVRDN
RSI
ODDS (%)
Bullish Trend 11 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
79%
Bearish Trend 11 days ago
85%
Momentum
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 11 days ago
85%
MACD
ODDS (%)
Bullish Trend 11 days ago
77%
N/A
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
79%
Bearish Trend 11 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend about 1 month ago
85%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ELFNX89.950.90
+1.01%
Elfun Trusts
FGIPX15.120.12
+0.80%
Macquarie Growth and Income Instl
FEFAX25.960.17
+0.66%
First Eagle Rising Dividend Fund A
THORX36.730.24
+0.66%
Thornburg Global Opportunities R3
GMEYX11.74N/A
N/A
GuideStone Funds Impact Equity Instl

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with ALLO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
+6.27%
ALLO - VRDN
51%
Loosely correlated
-1.09%
FATE - VRDN
48%
Loosely correlated
+1.60%
AURA - VRDN
47%
Loosely correlated
+1.30%
CRBU - VRDN
45%
Loosely correlated
-0.65%
ABCL - VRDN
45%
Loosely correlated
+1.02%
More